CounterPunch

Human Gene Editing and the CRISPR Revolution

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child ...

9 Best Gene-Editing Stocks to Buy According to Hedge Funds

Genetic manipulation – or gene editing – is a concept that describes altering the genetic material (DNA) of an organism.

Researchers to test gene therapy for rare diseases with a new FDA trial protocol

Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to ...
JD Supra

Finalized Changes to Medicare Payment Rules: Key Takeaways for Life Sciences Companies

The Centers for Medicare & Medicaid Services (“CMS”) recently finalized a Medicare payment rule with significant implications for life ...
STATOpinion

Celebrating a new, faster path to gene-editing medicines on demand

The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...
ZME Science on MSN

Inside the Human Gene Editing Boom Driven by CRISPR Reshaping Everything From Medicine to Food

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...

Penn, CHOP will test gene therapy for rare diseases with new FDA trial protocol

Penn and CHOP researchers want to develop urea cycle disorder treatments using CRISPR gene-editing therapy. Get unlimited access to Inquirer.com and The Inquirer App, plus 5 articles each month to ...